Opt2mise 5


Patient clinical profile:

  • A1C between 8%-12%
  • Insulin requirements of 0.7-1.8 units/kg
  • Multiple daily injections therapy (3+ injections per day) with or without combination with other oral or non-insulin injectable agents.
  • Facing challenges to meet A1C goals despite dosing titrations over at least the last 3 months.

To download a copy of the OpT2mise clinical summary in PDF form Click Here.

To download a copy of The Lancet study Click Here. and enter your email address.
OpT2mise clinical summary in PDF

Reznik Y, Cohen O, Aronson R, et al. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomized open-label controlled trial. The Lancet. 2014. DOI 10.1016/S0140-6736(14)61037-0.

First Name
Last Name
Email
By registering on this website, I represent that I am a healthcare professional and all information provided will be accurate and current to the best of my knowledge:

By downloading a copy of the study article/publication, I certify that I am a licensed healthcare professional in the U.S., and my review of the article/publication will be for research, education, and/or clinical purposes. Agree